Literature DB >> 22114546

Best of the AUA Annual Meeting: Highlights From the 2011 American Urological Association Meeting, May 14-19, 2011, Washington, DC.

Michael K Brawer1, Stacy Loeb, Alan W Partin, Jayabalan Nirmal, Michael B Chancellor, J Curtis Nickel, Jacob Rajfer, Ellen Shapiro, Claus G Roehrborn.   

Abstract

Keywords:  Botulinum toxin; Caffeine; Chemoprevention; Electromagnetic stimulation; Implications of childhood malignancies; Inflammation; PCA3 gene; Prostate markers; Prostate-specific antigen; Spermatogenesis identification; Testosterone

Year:  2011        PMID： 22114546      PMCID： PMC3222926     

Source DB:  PubMed          Journal:  Rev Urol        ISSN： 1523-6161


× No keyword cloud information.
  42 in total

1.  Effect of dutasteride on the risk of prostate cancer.

Authors:  Gerald L Andriole; David G Bostwick; Otis W Brawley; Leonard G Gomella; Michael Marberger; Francesco Montorsi; Curtis A Pettaway; Teuvo L Tammela; Claudio Teloken; Donald J Tindall; Matthew C Somerville; Timothy H Wilson; Ivy L Fowler; Roger S Rittmaster
Journal:  N Engl J Med       Date:  2010-04-01       Impact factor: 91.245

2.  Risk factors for end stage renal disease in non-WT1-syndromic Wilms tumor.

Authors:  Jane Lange; Susan M Peterson; Janice R Takashima; Yevgeny Grigoriev; Michael L Ritchey; Robert C Shamberger; J Bruce Beckwith; Elizabeth Perlman; Daniel M Green; Norman E Breslow
Journal:  J Urol       Date:  2011-06-17       Impact factor: 7.450

3.  Predicting age of ovarian failure after radiation to a field that includes the ovaries.

Authors:  W Hamish B Wallace; Angela B Thomson; Frank Saran; Tom W Kelsey
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-07-01       Impact factor: 7.038

4.  PSA screening among elderly men with limited life expectancies.

Authors:  Louise C Walter; Daniel Bertenthal; Karla Lindquist; Badrinath R Konety
Journal:  JAMA       Date:  2006-11-15       Impact factor: 56.272

5.  A randomized trial of prenatal versus postnatal repair of myelomeningocele.

Authors:  N Scott Adzick; Elizabeth A Thom; Catherine Y Spong; John W Brock; Pamela K Burrows; Mark P Johnson; Lori J Howell; Jody A Farrell; Mary E Dabrowiak; Leslie N Sutton; Nalin Gupta; Noel B Tulipan; Mary E D'Alton; Diana L Farmer
Journal:  N Engl J Med       Date:  2011-02-09       Impact factor: 91.245

6.  Detectable prostate-specific antigen Nadir during androgen-deprivation therapy predicts adverse prostate cancer-specific outcomes: results from the SEARCH database.

Authors:  Christopher J Keto; William J Aronson; Martha K Terris; Joseph C Presti; Christopher J Kane; Christopher L Amling; Stephen J Freedland
Journal:  Eur Urol       Date:  2012-12-06       Impact factor: 20.096

7.  Renal failure in Wilms' tumor patients: a report from the National Wilms' Tumor Study Group.

Authors:  M L Ritchey; D M Green; P R Thomas; G R Smith; G Haase; S Shochat; J Moksness; N E Breslow
Journal:  Med Pediatr Oncol       Date:  1996-02

8.  Second primary neoplasms in survivors of Wilms' tumour--a population-based cohort study from the British Childhood Cancer Survivor Study.

Authors:  Aliki J Taylor; David L Winter; Kathy Pritchard-Jones; Charles A Stiller; Clare Frobisher; Emma R Lancashire; Raoul C Reulen; Mike M Hawkins
Journal:  Int J Cancer       Date:  2008-05-01       Impact factor: 7.396

9.  Comparison of techniques for transurethral laser prostatectomy: standard photoselective vaporization of the prostate versus transurethral laser enucleation of the prostate.

Authors:  Dean S Elterman; Bilal Chughtai; Richard Lee; Lauren Kurlander; Marika Yip-Bannicq; Steven A Kaplan; Alexis E Te
Journal:  J Endourol       Date:  2013-02-21       Impact factor: 2.942

10.  Prostate cancer incidence among finasteride and alpha-blocker users in the Finnish Prostate Cancer Screening Trial.

Authors:  T J Murtola; T L J Tammela; L Määttänen; M Ala-Opas; U H Stenman; A Auvinen
Journal:  Br J Cancer       Date:  2009-08-04       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.